Literature DB >> 19733442

Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users.

Jichuan Wang1, Brian C Kelly, Brenda M Booth, Russel S Falck, Carl Leukefeld, Robert G Carlson.   

Abstract

The purpose of this study is to examine the factorial structure of the Brief Symptom Inventory 18 (BSI-18) and test its measurement invariance among different drug using populations. A total sample of 710 drug users was recruited using respondent-drive sampling (RDS) from three states: Ohio (n=248), Arkansas (n=237), and Kentucky (n=225). The results of confirmatory factor analysis (CFA) show: 1) the BSI-18 has a three-factor structure (somatization, depression, and anxiety) with an underlying second-order factor (global severity index of distress); and 2) its factorial structure and metric (factor loadings) are invariant across populations under study. However, the scalars (intercepts) of the BSI-18 items are not invariant, and the means of the latent factors also varied across populations. Our findings provide evidence of a valid factorial structure of the BSI-18 that can be readily applied to studying drug using populations.

Entities:  

Mesh:

Year:  2009        PMID: 19733442      PMCID: PMC3718020          DOI: 10.1016/j.addbeh.2009.08.003

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  36 in total

1.  Psychopathology as a predictor of adolescent drug use trajectories.

Authors:  H R White; M Xie; W Thompson; R Loeber; M Stouthamer-Loeber
Journal:  Psychol Addict Behav       Date:  2001-09

2.  Can test statistics in covariance structure analysis be trusted?

Authors:  L T Hu; P M Bentler; Y Kano
Journal:  Psychol Bull       Date:  1992-09       Impact factor: 17.737

3.  A practical and theoretical guide to measurement invariance in aging research.

Authors:  J L Horn; J J McArdle
Journal:  Exp Aging Res       Date:  1992 Autumn-Winter       Impact factor: 1.645

4.  Respondent-driven sampling to recruit MDMA users: a methodological assessment.

Authors:  Jichuan Wang; Robert G Carlson; Russel S Falck; Harvey A Siegal; Ahmmed Rahman; Linna Li
Journal:  Drug Alcohol Depend       Date:  2004-12-22       Impact factor: 4.492

5.  Somatization, anxiety and depression in a drug-free residential therapeutic community.

Authors:  Aaron S Metrikin; Marc Galanter; Helen Dermatis; Gregory Bunt
Journal:  Am J Addict       Date:  2003 Jan-Feb

Review 6.  Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.

Authors:  L Dixon
Journal:  Schizophr Res       Date:  1999-03-01       Impact factor: 4.939

7.  Chronically mentally ill patients with and without substance use disorders: a pilot study.

Authors:  A B Primm; M P Gomez; I Tzolova-Iontchev; W Perry; R M Crum
Journal:  Psychiatry Res       Date:  2000-09-11       Impact factor: 3.222

8.  Service use and costs of people with dual diagnosis in South London.

Authors:  P McCrone; P R Menezes; S Johnson; H Scott; G Thornicroft; J Marshall; P Bebbington; E Kuipers
Journal:  Acta Psychiatr Scand       Date:  2000-06       Impact factor: 6.392

9.  The relationship between anxiety and substance use disorders among individuals with severe affective disorders.

Authors:  Renee D Goodwin; David A Stayner; Matthew J Chinman; Ping Wu; Jacob Kraemer Tebes; Larry Davidson
Journal:  Compr Psychiatry       Date:  2002 Jul-Aug       Impact factor: 3.735

10.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08
View more
  28 in total

1.  "Ready, willing, and (not) able" to change: young adults' response to residential treatment.

Authors:  J F Kelly; K A Urbanoski; B B Hoeppner; V Slaymaker
Journal:  Drug Alcohol Depend       Date:  2011-09-28       Impact factor: 4.492

2.  Validity of the Brief Symptom Inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: Comparison with a Structured Clinical Diagnostic Interview.

Authors:  Christopher J Recklitis; Jaime E Blackmon; Grace Chang
Journal:  Psychol Assess       Date:  2017-01-12

3.  The role of therapeutic alliance in substance use disorder treatment for young adults.

Authors:  Karen A Urbanoski; John F Kelly; Bettina B Hoeppner; Valerie Slaymaker
Journal:  J Subst Abuse Treat       Date:  2012-01-28

4.  Chasing the bean: prescription drug smoking among socially active youth.

Authors:  Brian C Kelly; Mike Vuolo; Mark Pawson; Brooke E Wells; Jeffrey T Parsons
Journal:  J Adolesc Health       Date:  2015-06       Impact factor: 5.012

5.  Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder.

Authors:  Zev Schuman-Olivier; M Claire Greene; Brandon G Bergman; John F Kelly
Journal:  Drug Alcohol Depend       Date:  2014-09-18       Impact factor: 4.492

6.  Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders.

Authors:  André Q C Miguel; Brian D Kiluk; Theresa A Babuscio; Charla Nich; Jair J Mari; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2019-03-20       Impact factor: 4.492

7.  Social functioning outcomes among individuals with substance use disorders receiving internet-delivered community reinforcement approach.

Authors:  L A Marino; A N C Campbell; M Pavlicova; M Hu; E V Nunes
Journal:  Subst Use Misuse       Date:  2019-03-08       Impact factor: 2.164

8.  Contingency management treatments decrease psychiatric symptoms.

Authors:  Nancy M Petry; Sheila M Alessi; Carla J Rash
Journal:  J Consult Clin Psychol       Date:  2013-04-01

9.  Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Authors:  Sandra A Springer; Angela Di Paola; Marwan M Azar; Russell Barbour; Breanne E Biondi; Maureen Desabrais; Thomas Lincoln; Daniel J Skiest; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

10.  Recent Internet Use and Associations with Clinical Outcomes among Patients Entering Addiction Treatment Involved in a Web-Delivered Psychosocial Intervention Study.

Authors:  B Tofighi; A N C Campbell; M Pavlicova; M C Hu; J D Lee; E V Nunes
Journal:  J Urban Health       Date:  2016-10       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.